Latest Margin Expansion News

HiTech Group Australia posted a 3.2% revenue decline in FY26 to $65.6 million, with EBITDA down 35%, yet maintains a strong balance sheet and a 4 cent fully franked dividend. The company is progressing its acquisition of Hudson’s Australian operations, aiming to bolster growth and margins in FY27.

Cogstate Ltd (ASX:CGS) posted a 15.9% rise in profit before tax to US$16.1 million for FY26, driven by a 116% surge in clinical trial sales contracts to $89 million and a 15% revenue increase. The company doubled its final dividend to A$0.04 per share, supported by a strong $118.5 million contracted revenue backlog.

HUB24 Limited (ASX:HUB) delivered a standout FY26 with 23% revenue growth, 30% EBITDA increase, and record platform net inflows of $18.9 billion, while boosting dividends by 39%.

Amplitude Energy (ASX:AEL) posted record production and earnings for FY26, underpinned by strong operational execution and progress on the East Coast Supply Project (ECSP). The company strengthened its balance sheet, reduced net debt by 85%, and targets first gas from ECSP in 2028.

Vita Life Sciences delivered a robust first half in 2026 with revenue up 6.1% to A$48.3 million and net profit after tax rising 14.9% to A$5.54 million. The company declared a higher interim dividend, reflecting improved margins and regional market momentum.

Iress Limited’s half year net profit after tax surged 85% to $32 million, driven by sharp cost cuts and margin expansion, even as total revenue fell nearly 17% following recent divestments.

Amcor’s FY2026 results reflect the full impact of its 2025 Berry Global acquisition, with net sales soaring 57% to $23.5 billion and net income more than doubling to $1.1 billion. The company also announced a fiscal year-end change and a raised dividend.

Doctor Care Anywhere delivered a 27% rise in EBITDA and doubled free cash flow in H1 2026, driven by operational efficiencies and a strategic entry into the UK weight management market via acquisition.

Australian Clinical Labs (ASX: ACL) delivered a modest 1.7% underlying EBIT increase in FY26, navigating subdued revenue and rising labour costs with operational efficiencies and strategic initiatives.

IMDEX Limited (ASX:IMD) delivered a standout FY26 with 21% revenue growth to $520 million and a 44% jump in net profit to $79 million, driven by organic growth and five key acquisitions. The company raised its dividend and expanded its digital earth science footprint, positioning for further gains.

IPD Group reported record FY26 results, driven by robust data centre expansion and the Platinum Cables acquisition, delivering earnings above guidance and declaring a higher dividend.

Baby Bunting Group delivered a 6.5% revenue rise to $556 million in FY26, alongside a 33.9% jump in pro forma net profit after tax, driven by its Store of the Future refurbishments and margin expansion.